Druggio

Sanofi

Sanofi is a multinational pharmaceutical company with a diverse portfolio of prescription medicines, vaccines, and consumer healthcare products. Founded in 1973, Sanofi focuses on areas such as diabetes, cardiovascular diseases, rare diseases, multiple sclerosis, oncology, and vaccines. Some of their notable drugs include Lantus (insulin glargine) for diabetes, Dupixent (dupilumab) for atopic dermatitis and asthma, and Aubagio (teriflunomide) for multiple sclerosis. They are dedicated to advancing healthcare and improving the lives of patients around the world.

Sanofi's Drugs

Made by

Approval date

2021/9/27

Treats

Glycogen storage disease type II, Pompe disease

Made by

Approval date

2020/6/29

Treats

Multiple myeloma

Made by

Approval date

2018/7/2

Treats

Made by

Approval date

2018/1/19

Treats

Atopic dermatitis Asthma

Made by

Approval date

2017/9/27

Treats

Rheumatoid arthritis

Made by

Approval date

2017/3/30

Treats

Colorectal cancer

Made by

Approval date

2016/12/19

Made by

Approval date

2016/7/4

Treats

Familial hypercholesterolemia, Autosomal dominant hypercholesterolaemia Hyperlipidemia

Made by

Approval date

2016/3/28

Treats

Made by

Approval date

2016/3/28

Treats

West syndrome, Infantile spasms

Made by

Approval date

2015/7/3

Treats

Systemic lupus erythematosus Cutaneous lupus erythematosus

Made by

Approval date

2015/3/26

Treats

Gaucher disease

Made by

Approval date

2014/12/26

Treats

Made by

Approval date

2014/9/26

Treats

Chronic lymphocytic leukemia

Made by

Approval date

2014/7/4

Treats

Prostate cancer

Made by

Approval date

2014/7/4

Treats

Made by

Approval date

2014/7/4

Treats

Meningococcal infection

Made by

Approval date

2014/3/24

Treats

Multiple sclerosis

Deberza, Apleway

Made by

Approval date

2014/3/24

Treats

Type 2 diabetes mellitus

Made by

Approval date

2013/6/28

Treats

Type 2 diabetes mellitus

Made by

Approval date

2013/3/25

Treats

B-cell acute lymphoblastic leukemia, B-cell acute lymphocytic leukemia T-cell acute lymphoblastic leukemia, T-cell acute lymphocytic leukemia

Made by

Approval date

2012/4/27

Treats

Acute poliomyelitis, Polio

Made by

Approval date

2010/7/23

Made by

Approval date

2009/10/16

Made by

Approval date

2009/4/22

Treats

Type 1 diabetes mellitus Type 2 diabetes mellitus

Made by

Approval date

2008/7/16

Treats

Aplastic anemia Allograft rejection Graft-versus-host disease

Made by

Approval date

2008/1/25

Made by

Approval date

2007/10/4

Treats

Mucopolysaccharidosis type II, Hunter syndrome

Made by

Approval date

2007/4/18

Treats

Glycogen storage disease type II, Pompe disease

Made by

Approval date

2007/1/26

Treats

Haemophilus influenzae infection

Made by

Approval date

2006/10/20

Treats

Mucopolysaccharidosis type I, Hurler-Scheie syndrome, Hurler syndrome, Scheie syndrome

Made by

Approval date

2006/7/26

Treats

Multiple sclerosis

Made by

Approval date

2006/1/23

Made by

Approval date

2004/1/29

Treats

Fabry disease, Anderson-Fabry disease

Made by

Approval date

2003/10/16

Treats

Type 1 diabetes mellitus

Made by

Approval date

2003/4/16

Treats

Rheumatoid arthritis

Made by

Approval date

2002/1/17

Treats

Vancomycin-resistant enterococci infection

Spelear, Cleanal, Fudosteine

Made by

Sanofi Sanofi Sanofi Sanofi

Approval date

2001/10/2

Treats

Diffuse panbronchiolitis Asthma Chronic obstructive pulmonary disease (COPD), Emphysema Bronchiectasis with or without elevated sweat chloride Tuberculosis See 1 more disease(s)

Made by

Approval date

2001/4/4

Treats

Made by

Approval date

2000/9/22

Treats

Atopic dermatitis Allergic rhinitis